The Cardiac Rhythm Management market reports include research coverage on the following device segments: implantable cardioverter-defibrillators (ICDs), pacemakers, cardiac resynchronization therapy devices (CRTs), cardiac stimulation leads and wearable defibrillators.
iData’s market research will provide insights into the following questions:
How is COVID-19 the global Cardiac Rhythm Management Market?
What is the Cardiac Rhythm Management market size in the U.S.?
What factors are impacting the Cardiac Rhythm Management Market in the U.K.?
What is the number of total procedures in the Cardiac Rhythm Management market in Japan? What procedure volumes are on the rise or decline within the segments in Japan?
What are the major developments in the Cardiac Rhythm Management market in Germany? What impact did these have on the market share in Germany?
Which competitors hold more market share within the cardiac surgery instruments market in South Korea?
In 2020, the global pacemaker market size was valued at $2.26 billion, with over 450,000 pacemaker procedures performed annually. The market size is expected to further increase over the forecast period and reach $2.6 billion in 2025. Throughout this medical market research, we analyzed global pacemaker companies across more than 70 countries and used our comprehensive methodology
The total market for cardiac rhythm management devices in Europe is growing at a rate of 3.9%, which will take the 2018 market value of €2.2 billion up to €2.9 billion by 2025. Reprocessed diagnostic electrophysiology (EP) catheters accounted for a significant percentage of all diagnostic EP catheters used. Reprocessed catheters have a much lower
Industry Trends Heart failure affects over five million people annually in the U.S. alone and is the costliest cardiovascular illness, with upwards of $30 billion spent on managing heart failure each year. Cardiac rhythm management devices, such as pacemakers, ICDs and CRT devices, are implanted in patients with arrhythmias to correct cardiac pacing and/or to
In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the
This global market research includes conventional EP catheters and advanced EP catheters analyzed as a combined market segment. The analysis also covers radiofrequency (RF) cardiac ablation catheters and cryoablation catheters.
The global cardiac leads market size is expected to reach over $2,197 million by 2025, with the left ventricular (LV) lead market segment showing the highest growth. The majority of the global cardiac leads market share was controlled by Medtronic, Abbott, and Boston Scientific. Overall, this global market research includes an analysis ofcardiac leads companies spawning across more than 70 countries in the world.
The Asia Pacific countries that are covered in this report include: Japan, South Korea and Australia.
This report on cardiac rhythm management (CRM), electrophysiology and ablation devices analyzes the Asia Pacific market for medical devices used for diagnosing and treating cardiac arrhythmias. Medical device markets included in this report include those
for: implantable cardioverter defibrillators (ICDs), pacemakers, cardiac Resynchronization therapy (CRT) devices, cardiac stimulation leads, external defibrillators, ablation catheters and diagnostic electrophysiology (EP) catheters.